[00:23:37] And for me, I found it really interesting how they're working mechanistically, that they're helping with insulin sensitivity, they're helping with a reduction in appetite, they're helping with neuroinflammation, as you mentioned
Administration involves 1.75 mg subcutaneous injection used as needed, at least 45 minutes before anticipated activity
Small molecule inhibitors of ARG2 have been shown to upregulate the immune activity and almost completely counteract the immunosuppression, suggesting that ARG2 can be used as a target for the immunotherapy of AML (Mussai et al., 2013)
Published research on 5-Amino-1MQ is indexed on PubMed
Is a soft chew better than a powder
Our goal is to translate the medical record into legal leverageshowing precisely how a preventable reaction caused irreversible vision loss